Short answer: yes. Mounjaro (tirzepatide) is licensed across the UK, and Solira delivers it to Northern Ireland addresses as to the rest of the UK: QuickCare Pharmacy, the registered pharmacy that dispenses Solira orders (GPhC 9013213), sends every pen by Royal Mail Tracked 24 in a cool package, for the same delivery charge as everywhere else in the UK. On the Health Service in Northern Ireland the position is different. The NI Formulary's patient leaflet on tirzepatide, published in April 2025 and still the document it shows as of November 2026, says it is "not currently available through the Health Service in Northern Ireland for the treatment of obesity". The Department of Health endorsed NICE's guidance on tirzepatide in January 2025, and its new Regional Obesity Management Service, whose phase one is for adults with a BMI above 45 and at least one listed condition, was still being set up when we read nidirect on 1 November 2026. If you already take Mounjaro with another provider, you can usually carry on at your current dose with us, with proof of your last supply.
This guide sets out, as of November 2026, what the Health Service in Northern Ireland offers and to whom, how an order from Solira reaches a Northern Ireland address and what the delivery costs, how to switch from another provider without starting again, and how to check that an online pharmacy is registered.
Can you get Mounjaro in Northern Ireland?
Yes: privately, through an online service such as Solira, whose orders are dispensed by a registered pharmacy, and in time through the Health Service for a small group of adults with the highest clinical need, covered in the next section. Mounjaro's licence covers Northern Ireland as it does England, Scotland and Wales, because since 1 January 2025 the MHRA licenses medicines for the whole of the UK: weight management in adults with a BMI of 30 or above, or 27 to under 30 with at least one weight-related condition, alongside a reduced-calorie diet and more physical activity (UK product information, section 4.1). Our BMI calculator gives you the figure the check uses. This is who treatment may suit with us:
Treatment may be suitable if you're aged 18–84 and have a BMI of 30 or above, or a BMI of 27–29.9 alongside one of the following: high blood pressure, raised cholesterol or blood fats, obstructive sleep apnoea, cardiovascular disease, prediabetes, or type 2 diabetes.
Our consultation asks the same questions wherever in the UK you live: your height and weight, your health and the medicines you take, whether you have taken a GLP-1 weight loss medicine before and, if you are switching, proof of your current treatment. A GPhC-registered pharmacist reviews every answer before anything is supplied; we do not supply anyone under 18 or aged 85 or over, or anyone who is pregnant, breastfeeding or trying to conceive. Supplied only if your pharmacist decides it is suitable for you. The doses are the same everywhere too: 2.5mg once a week for 4 weeks, then 5mg, with any further step of 2.5mg after at least 4 weeks on the current dose, and 5mg, 10mg and 15mg as the maintenance doses (section 4.2), set out in our Mounjaro dosage chart.
Is Mounjaro available on the Health Service in Northern Ireland?
Not yet, for most people, as of November 2026. Northern Ireland's health service is Health and Social Care, usually called the HSC or simply the Health Service, rather than the NHS, and it decides for itself which NICE recommendations it adopts. The NI Formulary's patient leaflet on tirzepatide, published in April 2025 and still the document its obesity page shows when we read it on 1 November 2026, says: "Tirzepatide is not currently available through the Health Service in Northern Ireland for the treatment of obesity", that it "will be introduced as a phased approach, over a number of years", and asks people not to ask their GP practice to prescribe it. The route it will come through is a new Regional Obesity Management Service, and that service's phase one is for a small, tightly defined group.
Why endorsement did not mean availability: NICE's guidance is written for the NHS in England and "does not automatically apply" in Northern Ireland, the Department of Health's circular HSC (SQSD) 12/22 says. Since 2006 the Department has reviewed each NICE technology appraisal for its legal, policy and financial fit, and where it fits, endorsed it for the Health and Social Care system; the review checks those consequences, not the clinical evidence. NICE recommended tirzepatide on 23 December 2024 for adults with a BMI of at least 35 and at least one weight-related condition (TA1026, whose full criteria are on NICE's page), and the Department lists TA1026 among the appraisals it endorsed in January 2025. Endorsement is a decision that the guidance applies; a service still has to be commissioned. On 6 June 2025 the Department's Strategic Planning and Performance Group told hospital clinicians not to recommend tirzepatide for obesity and GPs not to prescribe it, because "there are currently no commissioned services to support prescribing", and said the new service would be the way in.
| When | What happened in Northern Ireland |
|---|---|
| 23 December 2024 | NICE publishes TA1026, recommending tirzepatide for adults with a BMI of at least 35 and at least one weight-related condition. Its funding duty and phased rollout apply to the NHS in England |
| January 2025 | The Department of Health endorses TA1026 as applicable in Northern Ireland |
| April 2025 | The NI Formulary publishes its patient leaflet: tirzepatide not currently available through the Health Service for obesity; a phased approach over a number of years; do not ask your GP practice to prescribe it |
| 21 May 2025 | The Health Minister announces a Regional Obesity Management Service, phase one to start in early 2026, with patient numbers limited at first |
| 6 June 2025 | The Department's service notification on TA1026: no commissioned service yet, so hospital clinicians should not recommend tirzepatide for obesity and GPs should not prescribe it |
| 18 May 2026 | The Department answers a Freedom of Information request: the pathway is "currently under development", and no prescribing guidance or referral criteria are held yet |
| 29 June 2026 | Phase one announced: a £5 million service for adults aged 18 and over with a BMI above 45 and at least one of five listed conditions, expected to roll out in early autumn 2026 |
| 1 November 2026 (read) | nidirect: "Work is ongoing to establish the new service", with details of how to access it "available soon". The April 2025 leaflet is still the NI Formulary's current document |
Phase one of the Regional Obesity Management Service is for adults aged 18 and over with a BMI above 45 and at least one of these conditions, in nidirect's words: cardiovascular disease (including ischaemic heart disease, stroke, peripheral vascular disease and heart failure); high blood pressure that needs medication; raised cholesterol or triglycerides; obstructive sleep apnoea confirmed by a sleep study; or type 2 diabetes. After an assessment, a care plan may include "weight loss medication, where appropriate", alongside lifestyle support and in line with NICE guidance; the Department's announcement names no medicine. A separate Obesity Pathway Innovation Programme takes self-referrals from adults with a BMI of 30 to 44.9: nidirect describes it as structured, personalised support, with a digital programme open to everyone and other parts available in selected areas, and does not mention medication for it.
So if you live in Northern Ireland and your BMI is under 45, or you have none of the five conditions, there is no Health Service route to Mounjaro for weight management yet, and your GP practice cannot prescribe it for that purpose or, the leaflet says, take over a private prescription on the Health Service. Prescriptions dispensed in Northern Ireland are free for everyone, so anyone the new service does treat would pay nothing for the medicine. How the other three nations compare is in our guide to weight loss injections on the NHS, and the rollout in England in Mounjaro on the NHS.
| As of November 2026 | Health Service in Northern Ireland | Privately, through Solira |
|---|---|---|
| Who can get it | Phase one of the Regional Obesity Management Service: adults aged 18 and over with a BMI above 45 and at least one of the five listed conditions, once it opens | Adults aged 18 to 84 with a BMI of 30 or above, or 27 to 29.9 with a weight-related condition, if the pharmacist decides it is suitable |
| How you get it | Through the new service; nidirect says details of how to access it will be available soon. Not from your GP practice | An online consultation, a GPhC-registered pharmacist's review, then delivery to your door |
| Which medicine | "Weight loss medication, where appropriate", in line with NICE guidance; the Department names none | Mounjaro, Wegovy or one of the weight loss tablets we offer, at the licensed doses, if your pharmacist decides it is suitable |
| What you pay | Nothing for the prescription: all prescriptions dispensed in Northern Ireland are free | The price of your dose, the same on every order, plus tracked delivery in a cool package |
Does Solira deliver Mounjaro to Northern Ireland?
Yes. We deliver to UK addresses, and a Northern Ireland address is a UK address: our checkout takes it like any other, and the same pharmacist review, the same pen and the same cool package apply. Pens go by Royal Mail Tracked 24 in a cool package, for £3.99 a parcel, the same charge as everywhere else in the UK; tablets and capsules go by Royal Mail Tracked 48. The parcel is plain, with no medicine names on it. We do not deliver to the Republic of Ireland.
How an order reaches Northern Ireland
Answer the consultation online. A few minutes: your height and weight, your health, the medicines you take and, if you are switching, proof of your current treatment.
A GPhC-registered pharmacist reviews it. Nothing is supplied until your pharmacist has approved your order. We aim to dispatch within 1 working day of approval.
Label printed, pen packed cold. We record your order as dispatched when its label is printed, and your dispatch email carries the tracking number. The pen travels in a cool package.
With Royal Mail. Royal Mail aims to deliver Tracked 24 parcels the next working day. These are Royal Mail's aims, not guarantees. Tracking starts at Royal Mail's first scan.
Delivered, and into the fridge. To your door, your safe place or a neighbour. Put the pen in the fridge as soon as it arrives. If a cold parcel was left outside for more than a few hours, message your pharmacist before you open anything in it.

Why the cool package matters: an unopened Mounjaro KwikPen is kept in the fridge at 2°C to 8°C and must never be frozen, and once you have started a pen it can be out of the fridge, not above 30°C, for up to 30 days, after which it is thrown away (UK product information, section 6.4). A pen that has been frozen must not be used. Each pen holds 4 weekly doses, and because the KwikPen comes without needles (section 6.5), we send pen needles and antiseptic wipes with every pen. The full storage limits, and travelling with pens, are in our guide to Mounjaro and Wegovy storage, and the needles in Mounjaro KwikPen needles.
If nobody is in, Royal Mail may leave the parcel in your safe place or with a neighbour, or put a card through your door so you can rebook or collect it (what happens if you are not in). If a parcel arrives warm, do not use anything in it until you have messaged your pharmacist with your order number and a photo; if it needs replacing we replace it or refund you in full. Everything else about how an order is sent is on our delivery page.
How much does Mounjaro cost in Northern Ireland?
Privately, what you pay depends on your dose, and with Solira it is the same in Northern Ireland as anywhere else in the UK: every dose's price is on our Mounjaro page, beside a dated table of what other UK providers charge, and the delivery charge above is the other cost. The price for each dose is the same on your first order and every one after. No introductory prices. There is no consultation fee and no subscription: you pay when you order and can stop after any pen, as our guide to weight loss medication without a subscription explains. Every pen order includes the pharmacist's review, the prescription, the needles and wipes, and messaging with your pharmacist from your account. Supplied only if your pharmacist decides it is suitable for you. How the price moves with the dose, and how to read a comparison, is in Mounjaro price comparison UK.
On the Health Service a prescription costs nothing, but as above the medicine is to come through the new service, for a defined group.
Not started treatment yet? Check whether it's suitable for you in a few minutes. A GPhC-registered pharmacist reviews every assessment, and if they can't approve your order, you get a full refund.
Check your eligibilityCan you switch to Solira from another provider in Northern Ireland?
Usually, yes, without starting again at 2.5mg, if your last dose was under three months ago and you can show proof of it. Proof is any one of these: your previous provider's approval email, a photo of your prescription, or a photo of the dispensing label, uploaded in the consultation or after you pay. Your pharmacist checks it before anything is supplied, and can usually continue the dose you are on, on the same medicine. If your last dose was in the last 4 weeks and you have been on that dose for 4 weeks or more, we usually suggest the next dose up, and you can choose to stay on yours. Three months or more since your last dose, and treatment restarts at the lowest dose and builds up again; it is counted from the date of your last dose, not your last order, and your pharmacist makes the final decision. If you have had Mounjaro from a pharmacy in Northern Ireland, its dispensing label or approval email is proof in the same way.
We do not contact your current provider. Keep using your current supply until we approve your order, then stop your repeat with them, because taking GLP-1 treatment from two places at once is unsafe. The steps are on our switching page; changing medicine as well as provider, from Wegovy to Mounjaro or the other way round, is in switching between Mounjaro and Wegovy; and coming back after a gap is in restarting Mounjaro or Wegovy after a break.
Is it safe to buy Mounjaro online in Northern Ireland?
It is, from a registered pharmacy, and the check is the same wherever in the UK you live: find the pharmacy on a regulator's register before you order. The NI Formulary's leaflet passes on the MHRA's advice that a genuine weight loss medicine comes from a legitimate pharmacy, including one trading online, against a prescription issued by a healthcare professional, and that unauthorised sellers may supply fake or unlicensed products. Two registers cover the UK. The General Pharmaceutical Council registers pharmacies in Britain, that is England, Scotland and Wales: QuickCare Pharmacy, the registered pharmacy that dispenses Solira orders, is pharmacy 9013213, and you can check that entry on the GPhC register. A pharmacy based in Northern Ireland is registered instead with the Pharmaceutical Society NI, the regulator for pharmacies and pharmacists in Northern Ireland, which has its own public register. The GPhC's register page also links the MHRA's check of whether a website is on its "Not Recommended" list.
The medicine itself does not change with the address. Mounjaro is one licensed product, the tirzepatide KwikPen made by Eli Lilly, supplied through the licensed UK supply chain whoever dispenses it, so what differs between providers is the price, the delivery and the service around the pen. The medicine's own safety, side effects and the MHRA's warnings are in Is Mounjaro safe?
What is different in the consultation if you live in Northern Ireland?
Almost nothing: the questions are the same, and two small things work differently. The box that finds your GP surgery searches the NHS list of practices in England and Wales, so with a Northern Ireland postcode it shows "The NHS list we search covers surgeries in England and Wales only, so please enter your surgery's name and address here." and you type your surgery's name and address in. We ask whether you would like us to tell your GP about your treatment, and we do so only with your consent (telling your GP); it is worth saying yes, because a GP who knows you take Mounjaro can take it into account in your other care. The NI Formulary's leaflet notes that a GP practice cannot take over a private prescription on the Health Service, so your supply continues with us for as long as you and your pharmacist decide to carry on, one order at a time.
Is Wegovy available in Northern Ireland?
Privately, yes: Wegovy (semaglutide) is supplied through Solira to Northern Ireland addresses in the same way as Mounjaro, by Royal Mail Tracked 24 in a cool package. On the Health Service the answer is the same as for Mounjaro: not yet. NICE recommends semaglutide for weight management within a specialist weight management service, for adults with at least one weight-related condition and a BMI of 35 or above, or 30 to 34.9 who meet the criteria for specialist referral (TA875), and the NI Formulary's leaflet says Northern Ireland "does NOT currently have such a specialist weight management service", so Wegovy and Saxenda "are also not yet available to prescribe on the Health Service". The June 2025 service notification says the new Regional Obesity Management Service "will enable access to a range of GLP1 agonists, including tirzepatide", and nidirect calls it a specialist weight management service, so which medicines it prescribes is for the service to publish. Wegovy pens have their own storage limits, in our guide to how long Wegovy can be out of the fridge, and the two medicines are compared in Mounjaro vs Wegovy. Every treatment we offer is on our weight loss page.

